Showing results (111-120 of 831) with videos related to
Sort By:
Pageof 84
Blood|March 5, 2004
VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemiaYean K Lee, Nancy D Bone, Ann K Strege, et al.Cancer|March 9, 2010
Central nervous system prophylaxis in adults with acute lymphoblastic leukemia: current and emerging therapiesElias Jabbour, Deborah Thomas, Jorge Cortes, et al.The Journal of Neuropsychiatry and Clinical Neurosciences|July 21, 2004
Cognitive dysfunction and depression during treatment with interferon-alpha and chemotherapyRandall S Scheibel, Alan D Valentine, Susan O'Brien, et al.Annals of Internal Medicine|December 21, 2006
New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistanceHagop M Kantarjian, Moshe Talpaz, Francis Giles, et al.Journal of Neuro-Oncology|January 26, 2007
Successful treatment of cancer-associated retinopathy with alemtuzumabLadan Espandar, Susan O'Brien, Charles Thirkill, et al.Leukemia & Lymphoma|April 4, 2013
Acute lymphoblastic leukemia in adults: encouraging developments on the way to higher cure ratesMichael S Mathisen, Hagop Kantarjian, Deborah Thomas, et al.Cancer|November 25, 2003
Imatinib mesylate causes hypopigmentation in the skinAnne S Tsao, Hagop Kantarjian, Jorge Cortes, et al.Cancer|March 28, 2006
Complete response in multiple myeloma: clinical trial E9486, an Eastern Cooperative Oncology Group study not involving stem cell transplantationRobert A Kyle, Traci Leong, Shuli Li, et al.Clinical Lymphoma, Myeloma & Leukemia|December 3, 2014
Progress in acute myeloid leukemiaTapan M Kadia, Farhad Ravandi, Susan O'Brien, et al.Cancer|April 25, 2003
Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experienceGuillermo Lazo, Hagop Kantarjian, Elihu Estey, et al.Pageof 84